GENEVA, May 26 -- SHENZHEN TARGETRX, INC. (Third Floor, Building A1 Kexing Science Park, No. 15 Of Keyuan Road, Yuehai Subdistrict, Nanshan DistrictShenzhen, Guangdong 518057), 深圳市塔吉瑞生物医药有限公司 (中国广东省深圳市南山区粤海街道科苑路15号科兴科学园A1单元3楼) filed a patent application (PCT/CN2024/132017) for "METHOD FOR TREATING ALK-POSITIVE OR ROS1-POSITIVE NON-SMALL CELL LUNG CANCER" on Nov 14, 2024. With publication no. WO/2025/103408, the details related to the patent application was pu...